In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
Memorial Sloan Kettering Ralph Lauren Center nurse Jasmine Gibson, breast cancer patient Maria Tucker, and nurse Margaret Bediones
Expert Breast Cancer Treatment in Harlem at MSK’s Ralph Lauren Center

See how experts at Memorial Sloan Kettering Cancer Center's Ralph Lauren Center cared for Maria close to home.
Young female cancer patient holding a tea cup
Q&A
Preventing Nausea and Vomiting after Cancer Treatment: 7 Questions with an MSK Expert

Medical oncologist Mark Kris discusses how new guidelines for preventing nausea and vomiting due to treatment can improve quality of life for people with cancer.
Immunotherapy is a powerful tool against cancer. How does it work? Who can it help? MSK expert Dr. Michael Postow has answers
Treating Cancer With Immunotherapy: FAQ

Learn the most frequently asked questions about immunotherapy, a form of cancer treatment that uses the body's own immune system to overpower cancer cells. Learn who it can help, how it works, and how experts at MSK are finding ways to make it benefit more people, including new combinations with other cancer treatments like chemotherapy, surgery, radiation and more.
CAR T cell therapy
In the Clinic
CAR T Cell Therapies Are a Growing Area of Research

Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research.
MSK physician scientist Piro Lito, MD, PhD
Q&A
A Potential Advance Against RAS Gene-Driven Cancers

Learn about insights that could lead to a new class of drugs against cancers caused by RAS gene mutations.
A female nurse talks with a female patient, who is sitting in an exam chair
Feature
A Decade of Progress in Cancer Care, and What’s Next

Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.
Enlarged microscopic image of blue-green immune cells surrounding one blue cancer cell.
Q&A
Immunotherapy Offers New Strategy for Treating Sarcoma

Some of the first clinical trials testing immunotherapy for the treatment of sarcoma are now under way at MSK. Here’s a snapshot of where the research stands.
MSK researcher in a lab
MSK Research Highlights, August 24, 2023

New MSK research suggests a method for revealing DNA repair “scars” could help make treatment decisions in BRCA1- and BRCA2-deficient cancers; modified a bacteria-made compound to target mutant KRAS-driven cancers; and shed new light on brain metastasis in non-small cell lung cancer.
msk patient christopher jeter and his wife connie
You’ve Finished Cancer Treatment. Now What? MSK’s Survivorship Program Provides Expert Care

Meet Christopher Jeter, who was diagnosed nearly 10 years ago with lung cancer. He was successfully treated at Memorial Sloan Kettering and now is being closely monitored by experts in MSK's Adult Survivorship Program.
Allison Betof Warner uses a pipette in the lab
Multiplying the Army of Cancer-Fighting Immune Cells

Using patients’ own immune systems to fight cancer has been one of the most exciting advances in cancer treatment over the past decade. Now, a new immunotherapy could take this approach to the next level.